Saturday , November 18 2017
Home / Letter From The Editor / July 22, 2017

July 22, 2017

daveIt seems every week the SGLT-2 inhibitors are in the news, one time good and one time bad. Now there is a new study that shows that these products may have the ability to protect the kidneys in patients with type 2 diabetes.

Since we have had so many articles on both sides of the aisle, we decided to go to one of our board members and one of the foremost kidney experts, Dr. George Bakris, and get his feedback on this new indication for SGLT-2 inhibitors.

When Steve and Joy sat down with him, he wanted to cover more than just the kidney protective study, and we have a set of interviews for you covering almost everything related to diabetes, cardiovascular issues and kidney disease.

 

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief